drugset / Trial / NCT01619332
Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763
Parallel-groupQuadruple-blindTreatment
Summary
This study is a three part study to assess the safety and efficacy of LEZ763 on normal healthy volunteers and patients with Type 2 Diabetes.
Timeline
- Start
- 2012-03
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LEZ763 | Unknown | — | Oral |
| Comparator | Sitagliptin | Small molecule | — | Oral |